Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.
Huygens, Simone; Vellekoop, Heleen; Versteegh, Matthijs; Santi, Irene; Szilberhorn, László; Zelei, Tamás; Nagy, Balázs; Tsiachristas, Apostolos; Koleva-Kolarova, Rositsa; Wordsworth, Sarah; Rutten-van Mölken, Maureen.
Afiliação
  • Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Santi I; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Szilberhorn L; Syreon Research Institute, Budapest, Hungary.
  • Zelei T; Syreon Research Institute, Budapest, Hungary.
  • Nagy B; Syreon Research Institute, Budapest, Hungary.
  • Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, England, United Kingdom.
  • Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, England, United Kingdom.
  • Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, England, United Kingdom.
  • Rutten-van Mölken M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: m.rutten@eshpm.eur.nl.
Value Health ; 26(2): 193-203, 2023 02.
Article em En | MEDLINE | ID: mdl-36229359
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise de Custo-Efetividade / Neoplasias Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise de Custo-Efetividade / Neoplasias Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda